OVERVIEW
To gain real-world insight into what schizophrenia patients want in their treatment plans, we decided to ask them. I leveraged the survey results as a complimentary, unbranded method of promoting Long-Acting Injectables (LAIs) as the preferred treatment choice. I elevated the survey by branding it with an official name, logo, and visual identity that would ultimately be used in combination with approved branded content.
The Choices & Voices Patient Treatment Survey provided invaluable insights into the treatment preferences of individuals living with schizophrenia, especially regarding long-acting options. Many patients expressed a desire for their doctors to take the initiative in discussing longer-acting treatments, such as injectable medications, which can offer benefits like better adherence and symptom management. By capturing patients' voices, the survey empowered them in their treatment choices and highlighted the importance of shared decision-making in healthcare.
The Choices & Voices Patient Treatment Survey provided invaluable insights into the treatment preferences of individuals living with schizophrenia, especially regarding long-acting options. Many patients expressed a desire for their doctors to take the initiative in discussing longer-acting treatments, such as injectable medications, which can offer benefits like better adherence and symptom management. By capturing patients' voices, the survey empowered them in their treatment choices and highlighted the importance of shared decision-making in healthcare.
CATEGORY
Unbranded Pharmaceutical Marketing
Unbranded Pharmaceutical Marketing
AUDIENCE
HCP
HCP
AGENCY
DiD Agency / LUCID Group
DiD Agency / LUCID Group
CLIENT
J&J Innovative Medicines
J&J Innovative Medicines
ROLE
ACD, Copywriting, Art Direction & Visual Identity Design
ACD, Copywriting, Art Direction & Visual Identity Design